Pharmaceuticals as a market for “lemons”: Theory and practice
Author
Abstract
Suggested Citation
DOI: 10.1016/j.socscimed.2020.113368
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Huseyin Naci & Maximilian Salcher-Konrad & Aaron Kesselheim & Beate Wieseler & Lise Rochaix & Rita Redberg & Georgia Salanti & Emily Jackson & Sarah Garner & T Scott Stroup & Andrea Cipriani, 2020.
"Generating comparative evidence on new drugs and devices before approval,"
Post-Print
halshs-02875099, HAL.
- Huseyin Naci & Maximilian Salcher-Konrad & Aaron Kesselheim & Beate Wieseler & Lise Rochaix & Rita Redberg & Georgia Salanti & Emily Jackson & Sarah Garner & T Scott Stroup & Andrea Cipriani, 2020. "Generating comparative evidence on new drugs and devices before approval," PSE-Ecole d'économie de Paris (Postprint) halshs-02875099, HAL.
- Irving Kirsch & Brett J Deacon & Tania B Huedo-Medina & Alan Scoboria & Thomas J Moore & Blair T Johnson, 2008. "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration," PLOS Medicine, Public Library of Science, vol. 5(2), pages 1-9, February.
- Mary K. Olson, 2002. "Pharmaceutical Policy Change and the Safety of New Drugs," Journal of Law and Economics, University of Chicago Press, vol. 45(S2), pages 615-642.
- Olson, Mary K., 2004. "Are novel drugs more risky for patients than less novel drugs?," Journal of Health Economics, Elsevier, vol. 23(6), pages 1135-1158, November.
- Brody, H. & Light, D.W., 2011. "The inverse benefit law: How drug marketing undermines patient safety and public health," American Journal of Public Health, American Public Health Association, vol. 101(3), pages 399-404.
- Hneine Brax & Racha Fadlallah & Lina Al-Khaled & Lara A Kahale & Hala Nas & Fadi El-Jardali & Elie A Akl, 2017. "Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 12(4), pages 1-28, April.
- George A. Akerlof, 1970. "The Market for "Lemons": Quality Uncertainty and the Market Mechanism," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 84(3), pages 488-500.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Andreas Schick & Kathleen L. Miller & Michael Lanthier & Gerald Dal Pan & Clark Nardinelli, 2017. "Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals," Drug Safety, Springer, vol. 40(6), pages 497-503, June.
- Samuel DeCanio, 2024. "Cost benefit analysis and the FDA: measuring the costs and benefits of drug approval under the PDUFA I-II, 1998–2005," Journal of Regulatory Economics, Springer, vol. 66(2), pages 174-180, December.
- Philipson, Tomas & Berndt, Ernst R. & Gottschalk, Adrian H.B. & Sun, Eric, 2008.
"Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts,"
Journal of Public Economics, Elsevier, vol. 92(5-6), pages 1306-1325, June.
- Philipson, Tomas J. & Berndt, Ernst R. & Gottschalk, Adrian H. B. & Sun, Eric, 2007. "Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts," Working Papers 217, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
- Guy David & Sara Markowitz & Seth Richards-Shubik, 2010.
"The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation,"
American Economic Journal: Economic Policy, American Economic Association, vol. 2(4), pages 1-25, November.
- Guy David & Sara Markowitz & Seth Richards, 2009. "The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation," NBER Working Papers 14634, National Bureau of Economic Research, Inc.
- Olson, Mary K., 2008. "The risk we bear: The effects of review speed and industry user fees on new drug safety," Journal of Health Economics, Elsevier, vol. 27(2), pages 175-200, March.
- Francisco Polidoro, 2020. "Knowledge, routines, and cognitive effects in nonmarket selection environments: An examination of the regulatory review of innovations," Strategic Management Journal, Wiley Blackwell, vol. 41(13), pages 2400-2435, December.
- Francisco Polidoro & Matt Theeke, 2012. "Getting Competition Down to a Science: The Effects of Technological Competition on Firms' Scientific Publications," Organization Science, INFORMS, vol. 23(4), pages 1135-1153, August.
- Anna Chorniy & James Bailey & Abdulkadir Civan & Michael Maloney, 2021. "Regulatory review time and pharmaceutical research and development," Health Economics, John Wiley & Sons, Ltd., vol. 30(1), pages 113-128, January.
- Assaf Razin & Efraim Sadka & Chi-Wa Yuen, 1999.
"An Information-Based Model of Foreign Direct Investment: The Gains from Trade Revisited,"
International Tax and Public Finance, Springer;International Institute of Public Finance, vol. 6(4), pages 579-596, November.
- Razin, Assaf & Sadka, Efraim & Yuen, Chi-Wa, 1998. "An Information-Based Model of Foreign Direct Investment: The Gains form Trade Revisited," Foerder Institute for Economic Research Working Papers 275636, Tel-Aviv University > Foerder Institute for Economic Research.
- Razin, A. & Sadka, E. & Yuen, C.-W., 1998. "An Information-Based Model of Foreign Direct Investment: the Gains from Trade Revisited," Papers 28-98, Tel Aviv.
- Assaf Razin & Efraim Sadka & Chi-Wa Yuen, 1999. "An Information-Based Model of Foreign Direct Investment: The Gains from Trade Revisited," NBER Working Papers 6884, National Bureau of Economic Research, Inc.
- Tisdell, Clem, 2014. "Information Technology's Impacts on Productivity, Welfare and Social Change: Second Version," Economic Theory, Applications and Issues Working Papers 195701, University of Queensland, School of Economics.
- Konduru, Srinivasa & Kalaitzandonakes, Nicholas G. & Magnier, Alexandre, 2009. "GMO Testing Strategies and Implications for Trade: A Game Theoretic Approach," 2009 Annual Meeting, July 26-28, 2009, Milwaukee, Wisconsin 49594, Agricultural and Applied Economics Association.
- König, Philipp J. & Pothier, David, 2018. "Safe but fragile: Information acquisition, sponsor support and shadow bank runs," Discussion Papers 15/2018, Deutsche Bundesbank.
- Andrea Attar & Thomas Mariotti & François Salanié, 2021.
"Entry-Proofness and Discriminatory Pricing under Adverse Selection,"
American Economic Review, American Economic Association, vol. 111(8), pages 2623-2659, August.
- Attar, Andrea & Mariotti, Thomas & Salanié, François, 2017. "Entry-Proofness and Discriminatory Pricing under Adverse Selection," TSE Working Papers 17-788, Toulouse School of Economics (TSE), revised Jan 2021.
- Andrea Attar & Thomas Mariotti & François Salanié, 2021. "Entry-proofness and discriminatory pricing under adverse selection," Post-Print hal-03353054, HAL.
- Andrea Attar & Thomas Mariotti & François Salanié, 2021. "Entry-proofness and discriminatory pricing under adverse selection," Working Papers hal-03485384, HAL.
- Reynolds, Travis & Kolodinsky, Jane & Murray, Byron, 2012. "Consumer preferences and willingness to pay for compact fluorescent lighting: Policy implications for energy efficiency promotion in Saint Lucia," Energy Policy, Elsevier, vol. 41(C), pages 712-722.
- Ginger Zhe Jin & Andrew Kato & John A. List, 2010.
"That’S News To Me! Information Revelation In Professional Certification Markets,"
Economic Inquiry, Western Economic Association International, vol. 48(1), pages 104-122, January.
- Ginger Zhe Jin & Andrew Kato & John A. List, 2006. "That's News to Me! Information Revelation in Professional Certification Markets," NBER Working Papers 12390, National Bureau of Economic Research, Inc.
- Ginger Jin & Andrew Kato & John List, 2006. "That's news to me! information revelation in professional certification markets," Framed Field Experiments 00162, The Field Experiments Website.
- Ritu Agarwal & Michelle Dugas & Guodong (Gordon) Gao & P. K. Kannan, 2020. "Emerging technologies and analytics for a new era of value-centered marketing in healthcare," Journal of the Academy of Marketing Science, Springer, vol. 48(1), pages 9-23, January.
- Villas-Boas, Sofia B, 2020. "Reduced Form Evidence on Belief Updating Under Asymmetric Information," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt08c456vk, Department of Agricultural & Resource Economics, UC Berkeley.
- Yaofeng Fu & Ruokun Huang & Yiran Sheng, 2017. "Labor Contract Law -An Economic View," Papers 1702.03977, arXiv.org.
- Ghosh, Suman, 2007.
"Job mobility and careers in firms,"
Labour Economics, Elsevier, vol. 14(3), pages 603-621, June.
- Suman Ghosh, 2004. "Job mobility and careers in firms," Working Papers 04025, Department of Economics, College of Business, Florida Atlantic University, revised Jul 2006.
- Eunsoo Kim & Suyon Kim & Jaehong Lee, 2021. "Do Foreign Investors Affect Carbon Emission Disclosure? Evidence from South Korea," IJERPH, MDPI, vol. 18(19), pages 1-14, September.
More about this item
Keywords
Akerlof; Clinical trials; Drug safety; Markets for lemons; Pharmaceuticals; Regulators;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:268:y:2021:i:c:s0277953620305876. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.